Chibro-Amuno en es it fr

Chibro-Amuno Brand names, Chibro-Amuno Analogs

Chibro-Amuno Brand Names Mixture

  • No information avaliable

Chibro-Amuno Chemical_Formula

C19H16ClNO4

Chibro-Amuno RX_link

http://www.rxlist.com/cgi/generic/indometh.htm

Chibro-Amuno fda sheet

Chibro-Amuno msds (material safety sheet)

Chibro-Amuno MSDS

Chibro-Amuno Synthesis Reference

No information avaliable

Chibro-Amuno Molecular Weight

357.787 g/mol

Chibro-Amuno Melting Point

158 oC

Chibro-Amuno H2O Solubility

0.937 mg/L

Chibro-Amuno State

Solid

Chibro-Amuno LogP

3.655

Chibro-Amuno Dosage Forms

Capsule

Chibro-Amuno Indication

For moderate to severe rheumatoid arthritis including acute flares of chronic disease, ankylosing spondylitis, osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.

Chibro-Amuno Pharmacology

Indomethacin, a nonsteroidal antiinflammatory drug (NSAID) with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.

Chibro-Amuno Absorption

No information avaliable

Chibro-Amuno side effects and Toxicity

No information avaliable

Chibro-Amuno Patient Information

Indomethacin, like other drugs of its class, is not free of side effects. The side effects of these drugs can cause discomfort and rarely, there are more serious side effects, such as gastrointestinal bleeding, which may result in hospitalization and even fatal outcomes. NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) are often essential agents in the management of arthritis, but they also may be commonly employed for conditions which are less serious. Physicians may wish to discuss with their patients the potential risks and likely benefits of NSAID treatment, particularly when the drugs are used for less serious conditions where treatment without NSAIDs may represent an acceptable alternative to both the patient and physician.

Chibro-Amuno Organisms Affected

Humans and other mammals